围手术期双联抗血小板治疗下支架辅助弹簧圈栓塞治疗急性破裂颅内动脉瘤的安全性与有效性
该回顾性研究纳入203例急性破裂颅内动脉瘤患者,比较支架辅助弹簧圈栓塞(SAC)与单纯弹簧圈栓塞的疗效与安全性。SAC组随访再通率显著更低(p=0.030),术后脑梗死发生率显著更低(8.2% vs 17.7%,p=0.044),但脑室造瘘相关出血率显著更高(26.2% vs 9.3%,p=0.031),症状性出血发生率相当。作者认为SAC联合围手术期双联抗血小板治疗可能是安全有效的治疗策略。
要点
- SAC组随访再通率显著低于单纯栓塞组(p=0.030),完全闭塞率有升高趋势(p=0.061)。
- SAC组术后脑梗死发生率显著低于单纯栓塞组(8.2% vs 17.7%,p=0.044)。
- SAC组脑室造瘘相关出血率显著高于单纯栓塞组(26.2% vs 9.3%,p=0.031),但症状性出血发生率相当。
核心结论
- SAC联合围手术期双联抗血小板治疗可能是急性破裂颅内动脉瘤安全有效的治疗策略,且可能对术后脑梗死有保护作用而不增加症状性出血并发症风险。
研究设计与样本
- 回顾性评估203例急性破裂颅内动脉瘤患者,分为SAC组与单纯弹簧圈栓塞组,比较血管造影结果、临床结局及手术相关并发症。
- 对未接受慢性抗血栓药物治疗的患者进行手术并发症亚组分析。
主要发现
- 130例(64.0%)接受单纯弹簧圈栓塞,73例(36.0%)接受SAC。
- SAC组血管造影随访完全闭塞率有升高趋势(p=0.061),再通率显著低于单纯栓塞组(p=0.030)。
- SAC组术后脑梗死发生率8.2%,单纯栓塞组17.7%,差异显著(p=0.044)。
- SAC组脑室造瘘相关出血率26.2%,单纯栓塞组9.3%,差异显著(p=0.031);症状性出血发生率相当。
- 排除接受慢性抗血栓药物治疗患者的亚组分析显示相似结果。
临床怎么用
- 作者认为SAC联合围手术期双联抗血小板治疗可能是急性破裂颅内动脉瘤安全有效的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Despite growing evidence for the effectiveness of stent-assisted coil embolization (SAC) in treating acutely ruptured aneurysms, the safety of stent placement in acute phase remains controversial because of concerns for stent-induced thromboembolism and hemorrhagic events attributable to the necessity of antiplatelet therapy. Therefore, we investigated the safety and efficacy of SAC with periprocedural dual antiplatelet therapy (DAPT) compared with the coiling-only technique to determine whether it is a promising treatment strategy for ruptured aneurysms. METHODS: We retrospectively evaluated 203 enrolled patients with acutely ruptured aneurysms, categorizing them into two groups: SAC and coiling-only groups. Comparative analyses between the two groups regarding angiographic results, clinical outcomes, and procedure-related complications were performed. A subgroup analysis of procedural complications was conducted on patients who did not receive chronic antithrombotic medications to alleviate their influence before hospitalization. RESULTS: 130 (64.0%) patients were treated using the coiling-only technique, whereas 73 (36.0%) underwent SAC. There was a trend to a higher complete obliteration rate (p = 0.061) and significantly lower recanalization rate (p = 0.030) at angiographic follow-up in the SAC group compared to the coiling-only group. Postprocedural cerebral infarction occurred less frequently in the SAC group (8.2%) than in the coiling-only group (17.7%), showing a significant difference (p = 0.044). Although the ventriculostomy-related hemorrhage rate was significantly higher in the SAC group than in the coiling-only group (26.2% vs. 9.3%, p = 0.031), the incidence of symptomatic ventriculostomy-related hemorrhage was comparable. Subgroup analysis excluding patients receiving chronic antithrombotic medications showed similar results. CONCLUSION: SAC with periprocedural DAPT could be a safe and effective treatment strategy for acutely ruptured aneurysms. Moreover, it might have a protective effect on postprocedural cerebral infarction without increasing the risk of symptomatic hemorrhagic complications.
引用
- Lee IH, Ha SK, Lim DJ, et al. Safety and efficacy of stent-assisted coil embolization with periprocedural dual antiplatelet therapy for the treatment of acutely ruptured intracranial aneurysms. Acta Neurochir (Wien). 2024. PMID: 38744753. doi:10.1007/s00701-024-06117-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。